Recent Finacing
Recent Raise
Allecra Therapeutics (Lörrach, Germany; Saint‑Louis, France) develops AAI202, a β‑lactam paired with a proprietary extended‑spectrum β‑lactamase inhibitor for hospitalized patients with multidrug‑resistant Gram‑negative infections.
Focus Areas
Recent Investors
Total Raised
Funding rounds
Investors